Found: 108
Select item for more details and to access through your institution.
Repurposing Revisited: Exploring the Role of Metformin for Treatment of COVID-19.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 2, p. 292, doi. 10.1093/cid/ciae154
- By:
- Publication type:
- Article
Recertification Revisited.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Personal Stories From a World Turned Upside Down: Introducing the Voices of ID Collection.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 1, p. 3, doi. 10.1093/cid/ciad588
- By:
- Publication type:
- Article
Oral Nirmatrelvir and Ritonavir for Coronavirus Disease 2019 in Vaccinated, Nonhospitalized Adults Aged 18–50 Years.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 9, p. 1257, doi. 10.1093/cid/ciad400
- By:
- Publication type:
- Article
Call to Action: Prioritizing the Use of Inclusive, Nonstigmatizing Language in Scientific Communications.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 10, p. 1860, doi. 10.1093/cid/ciad055
- By:
- Publication type:
- Article
Reply to Authors.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 4, p. 563, doi. 10.1093/cid/ciac673
- By:
- Publication type:
- Article
Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e450, doi. 10.1093/cid/ciab875
- By:
- Publication type:
- Article
Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 8, p. 1440, doi. 10.1093/cid/ciab444
- By:
- Publication type:
- Article
Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 2, p. e485, doi. 10.1093/cid/ciaa988
- By:
- Publication type:
- Article
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 1, p. 33, doi. 10.1093/cid/ciaa822
- By:
- Publication type:
- Article
Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 6, p. 1379, doi. 10.1093/cid/ciz999
- By:
- Publication type:
- Article
Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 8, p. 1636, doi. 10.1093/cid/ciz442
- By:
- Publication type:
- Article
Clinical Impact and Cost-effectiveness of Genotype Testing at Human Immunodeficiency Virus Diagnosis in the United States.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 7, p. 1353, doi. 10.1093/cid/ciz372
- By:
- Publication type:
- Article
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus–1 Infection: Week 48 Results of the DRIVE-AHEAD Trial.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 535, doi. 10.1093/cid/ciy540
- By:
- Publication type:
- Article
ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA <500 000 Copies/mL.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 11, p. 1689, doi. 10.1093/cid/cix1083
- By:
- Publication type:
- Article
Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral Therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Should We Be Testing for Baseline Integrase Resistance in Patients Newly Diagnosed With Human Immunodeficiency Virus?
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 8, p. 1274, doi. 10.1093/cid/cix542
- By:
- Publication type:
- Article
Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 8, p. 1266, doi. 10.1093/cid/cix547
- By:
- Publication type:
- Article
Impact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B Study.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, n. 11, p. 1612, doi. 10.1093/cid/cix176
- By:
- Publication type:
- Article
The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States.
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 6, p. 784, doi. 10.1093/cid/civ981
- By:
- Publication type:
- Article
The Clinical Role and Cost-Effectiveness of Long-Acting Antiretroviral Therapy.
- Published in:
- Clinical Infectious Diseases, 2015, v. 60, n. 7, p. 1102, doi. 10.1093/cid/ciu1159
- By:
- Publication type:
- Article
Antiretroviral Therapy and Efficacy After Virologic Failure on First-line Boosted Protease Inhibitor Regimens.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 6, p. 888, doi. 10.1093/cid/ciu367
- By:
- Publication type:
- Article
Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 9, p. 1297, doi. 10.1093/cid/ciu046
- By:
- Publication type:
- Article
Editorial Commentary: Can We Break the Habit of Routine CD4 Monitoring in HIV Care?
- Published in:
- Clinical Infectious Diseases, 2013, v. 56, n. 9, p. 1344, doi. 10.1093/cid/cit008
- By:
- Publication type:
- Article
Reply to Green.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Antiretroviral Therapy: Now "It Just Works".
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Blood (1→3)-b-D-Glucan as a Diagnostic Test for HIV-Related Pneumocystis jirovecii Pneumonia.
- Published in:
- Clinical Infectious Diseases, 2011, v. 53, n. 2, p. 197, doi. 10.1093/cid/cir335
- By:
- Publication type:
- Article
Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s.
- Published in:
- Clinical Infectious Diseases, 2011, v. 53, n. 2, p. 185, doi. 10.1093/cid/cir324
- By:
- Publication type:
- Article
Predicting Virologic Failure in an HIV Clinic.
- Published in:
- Clinical Infectious Diseases, 2010, v. 50, n. 5, p. 779, doi. 10.1086/650537
- By:
- Publication type:
- Article
HIV Preexposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost-Effectiveness.
- Published in:
- Clinical Infectious Diseases, 2009, v. 48, n. 6, p. 806, doi. 10.1086/597095
- By:
- Publication type:
- Article
Use of a Serum β-Glucan Assay for Diagnosis of HIV-Related Pneumocystis jiroveci Pneumonia in Patients with Negative Microscopic Examination Results.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence Barriers.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 8, p. 1, doi. 10.1093/ofid/ofad390
- By:
- Publication type:
- Article
IgM Positivity for Both EBV and CMV: A Clinical Conundrum.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 7, p. 1, doi. 10.1093/ofid/ofac316
- By:
- Publication type:
- Article
Sustained HIV Viral Suppression With Dolutegravir, Tenofovir, and Emtricitabine as Initial Therapy Despite High-Level Transmitted Multiclass Resistance.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 2, p. 1, doi. 10.1093/ofid/ofab648
- By:
- Publication type:
- Article
Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 1, p. 1, doi. 10.1093/ofid/ofab498
- By:
- Publication type:
- Article
Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 10, p. 1, doi. 10.1093/ofid/ofaa415
- By:
- Publication type:
- Article
Emergent Resistance to Dolutegravir Among INSTI-Naïve Patients on First-line or Second-line Antiretroviral Therapy: A Review of Published Cases.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 6, p. 1, doi. 10.1093/ofid/ofaa202
- By:
- Publication type:
- Article
No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized Trial.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 3, p. N.PAG, doi. 10.1093/ofid/ofz056
- By:
- Publication type:
- Article
Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa.
- Published in:
- Open Forum Infectious Diseases, 2017, v. 4, n. 2, p. 1, doi. 10.1093/ofid/ofx081
- By:
- Publication type:
- Article
Improving Influenza and Pneumococcal Vaccination Rates in Ambulatory Specialty Practices.
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 4, p. 1, doi. 10.1093/ofid/ofv119
- By:
- Publication type:
- Article
Generalizing evidence from randomized trials using inverse probability of sampling weights.
- Published in:
- Journal of the Royal Statistical Society: Series A (Statistics in Society), 2018, v. 181, n. 4, p. 1193, doi. 10.1111/rssa.12357
- By:
- Publication type:
- Article
Antiretroviral Drug Recommendations for HIV Treatment and Prevention-Reply.
- Published in:
- 2021
- By:
- Publication type:
- letter
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.
- Published in:
- JAMA: Journal of the American Medical Association, 2020, v. 324, n. 16, p. 1651, doi. 10.1001/jama.2020.17025
- By:
- Publication type:
- Article
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Potential Clinical Implications of Interlaboratory Variability in CD4+ T-Lymphocyte Counts of Patients Infected with Human Immunodeficiency Virus.
- Published in:
- Clinical Infectious Diseases, 1995, v. 21, n. 5, p. 1121, doi. 10.1093/clinids/21.5.1121
- By:
- Publication type:
- Article
Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Metabolic Effects of Rosiglitazone in HIV Lipodystrophy.
- Published in:
- Annals of Internal Medicine, 2004, v. 140, n. 10, p. 786, doi. 10.7326/0003-4819-140-10-200405180-00008
- By:
- Publication type:
- Article
HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0113031
- By:
- Publication type:
- Article